randomized double blind clinical trial
Showing 1 - 25 of >10,000
Myopia Trial in Taipei, Taoyuan (Soft Contact Lens)
Completed
- Myopia
- Soft Contact Lens
-
Taipei, Taiwan
- +1 more
Nov 7, 2023
Cerebral Small Vessel Diseases Trial (Tongxinluo Capsule)
Not yet recruiting
- Cerebral Small Vessel Diseases
- Tongxinluo Capsule
- (no location specified)
Sep 25, 2023
Bowel Preparation Trial in Nanjing (OSS, OSS+Linzess, PEG-Interferon Alfa)
Recruiting
- Bowel Preparation
- OSS
- +2 more
-
Nanjing, Jiangsu, ChinaA single-center, single-blind, randomized controlled clinical st
Oct 20, 2023
Recurrent Aphthous Ulcer Trial in Rome (OR-AT0222, Placebo)
Recruiting
- Recurrent Aphthous Ulcer
- OR-AT0222
- Placebo
-
Rome, ItalyPoliclinico "Umberto I" - U.O.C. di Odontoiatria Pediatrica ed O
Jul 17, 2023
Rheumatoid Arthritis Trial (VC005 tablets, VC005 Tablets Placebo)
Not yet recruiting
- Rheumatoid Arthritis
- VC005 tablets
- VC005 Tablets Placebo
- (no location specified)
May 24, 2023
Chronic Spontaneous Urticaria Trial in Canada, United States (Oral EP262, Placebo)
Recruiting
- Chronic Spontaneous Urticaria
- Oral EP262
- Placebo
-
Birmingham, Alabama
- +7 more
Oct 5, 2023
Osteo Arthritis Knee Trial in Lakitelek (• harpagozid • boswellin = LOXACON)
Active, not recruiting
- Osteo Arthritis Knee
- • harpagozid • boswellin = LOXACON
-
Lakitelek, HungaryLakitelek foundation
Jun 29, 2023
Generalized Anxiety Disorder Trial (Shugan Jieyu Capsules, Shugan Jieyu Capsules+Placebo, Placebo)
Not yet recruiting
- Generalized Anxiety Disorder
- Shugan Jieyu Capsules
- +2 more
- (no location specified)
Mar 6, 2023
Infertility, Female Trial (Metformin Hydrochloride, Placebo)
Not yet recruiting
- Infertility, Female
- Metformin Hydrochloride
- Placebo
- (no location specified)
Aug 22, 2023
Active Ankylosing Spondylitis Trial (VC005 tablets, Tofacitinib Citrate Tablets, VC005 Tablets Placebo)
Not yet recruiting
- Active Ankylosing Spondylitis
- VC005 tablets
- +2 more
- (no location specified)
Apr 4, 2023
Sporadic and Familial Amyotrophic Lateral Sclerosis Trial in Beijing (FB1006, Placebo)
Recruiting
- Sporadic and Familial Amyotrophic Lateral Sclerosis
- FB1006
- Placebo
-
Beijing, Beijing, ChinaPeking University Third Hospital
Jun 20, 2023
Spinal Cord Injuries, Neuropathic Pain Trial in Minneapolis (brivaracetam, Placebo)
Not yet recruiting
- Spinal Cord Injuries
- Neuropathic Pain
- brivaracetam
- Placebo
-
Minneapolis, MinnesotaUniversity of Minnesota
Dec 5, 2022
Neonatal Jaundice, Microtia, Pregnancy Related Trial (Vivomixx®, Placebo)
Not yet recruiting
- Neonatal Jaundice
- +2 more
- Vivomixx®
- Placebo
- (no location specified)
Oct 17, 2023
Moderate to Severe Atopic Dermatitis Trial in Nanjing (VC005 tablets, VC005 Tablets Placebo)
Recruiting
- Moderate to Severe Atopic Dermatitis
- VC005 tablets
- VC005 Tablets Placebo
-
Nanjing, Jiangsu, ChinaChinese Academy of Medical Sciences Hospital for Skin Diseases
Aug 16, 2023
Asthma Trial (XKH001 Injection, XKH001 Placebo Injection)
Not yet recruiting
- Asthma
- XKH001 Injection
- XKH001 Placebo Injection
- (no location specified)
Aug 13, 2023
Vasomotor Symptoms Trial in Peking (HS-10384 tablets, HS-10384-matched tablets)
Not yet recruiting
- Vasomotor Symptoms
- HS-10384 tablets
- HS-10384-matched placebo tablets
-
Peking, Beijing, ChinaPeking University Third Hospital
Nov 7, 2023
Psoriasis Trial in Shanghai (LZM012, Secukinumab)
Recruiting
- Psoriasis
- LZM012
- Secukinumab
-
Shanghai, Shanghai, ChinaHuashan Hospital
Oct 29, 2023
Parkinson Disease Trial in Rome (Transcranial direct current stimulation)
Recruiting
- Parkinson Disease
- Transcranial direct current stimulation
-
Rome, ItalyFlavia Torlizzi
Feb 21, 2023
Diabetes, Type 2 Trial in Changchun (AP026 (TQA2226) for injection, AP026 (TQA2226) for injection matching )
Recruiting
- Diabetes Mellitus, Type 2
- AP026 (TQA2226) for injection
- AP026 (TQA2226) for injection matching placebo
-
Changchun, Jilin, ChinaThe first hospital of Jilin University
Nov 16, 2023
Healthy Trial (CM326)
Not yet recruiting
- Healthy
- CM326
- (no location specified)
Jan 27, 2023
Covid19 Trial in Miami (ADX-629, Placebo)
Completed
- Covid19
- ADX-629
- Placebo
-
Miami, FloridaMedical Research Center of Miami II, Inc.
Sep 26, 2022